Adami et al. GCs as low as 2.5mg/day assoc bone loss in RMD. Preventable with anti-resporptives. GC>=5mg/day aHR 2.37 for fracture @RheumNow #ACR22 Abstr#L01 https://t.co/1Q8dDarcAB https://t.co/dW4glkerAL
Links:
Impact of Glucocorticoid Dosing and Anti-Osteoporotic Treatment on Bone Health …
https://acrabstracts.org/abstract/impact-of-glucocorticoid-dosing-and-anti-oste…
14-11-2022